TY - JOUR
T1 - Primary Uterine NUT Carcinoma
T2 - A Case Report and Literature Review
AU - Shiraishi, Tetsuro
AU - Kisu, Iori
AU - Kaneko, Naomi
AU - Fukuda, Takaaki
AU - Watanabe, Jun
AU - Hayashi, Ryoma
AU - Ueno, Akihisa
AU - Emoto, Katsura
AU - Nakamura, Kanako
AU - Nogami, Yuya
AU - Tsuji, Kosuke
AU - Masuda, Kenta
AU - Yamagami, Wataru
N1 - Publisher Copyright:
© 2026 by the authors.
PY - 2026/1
Y1 - 2026/1
N2 - Background: Nuclear protein in testis (NUT) carcinoma is a rare, aggressive, and poorly differentiated epithelial malignancy characterized by the rearrangement of NUTM1 (NUT midline carcinoma family member 1) on 15q14. It primarily originates along the midline structures, including the head, neck, thorax, and mediastinum. Although NUT carcinoma of the pelvic gynecological organs is exceedingly rare, reported cases have been limited to primary or metastatic ovarian tumors. Here, we present the first documented case of primary uterine NUT carcinoma. Case presentation: A 53-year-old postmenopausal woman presented with abnormal uterine bleeding and a uterine mass. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. The initial postoperative histopathological evaluation suggested undifferentiated endometrial sarcoma; however, subsequent immunohistochemical (IHC) analysis and fluorescence in situ hybridization revealed NUTM1 rearrangement, confirming the diagnosis of NUT carcinoma. The patient experienced tumor recurrence six months postoperatively and succumbed to the disease nine months later. Discussion: The pathological diagnosis was challenging; the presence of abrupt squamous differentiation prompted further IHC analysis, leading to the definitive diagnosis. Primary uterine NUT carcinoma may be misdiagnosed as other undifferentiated uterine tumors due to its rarity and histological overlap. Conclusions: Given the diagnostic challenges, NUT IHC staining and molecular testing for NUTM1 rearrangement should be considered in undifferentiated uterine tumors with ambiguous histopathological features.
AB - Background: Nuclear protein in testis (NUT) carcinoma is a rare, aggressive, and poorly differentiated epithelial malignancy characterized by the rearrangement of NUTM1 (NUT midline carcinoma family member 1) on 15q14. It primarily originates along the midline structures, including the head, neck, thorax, and mediastinum. Although NUT carcinoma of the pelvic gynecological organs is exceedingly rare, reported cases have been limited to primary or metastatic ovarian tumors. Here, we present the first documented case of primary uterine NUT carcinoma. Case presentation: A 53-year-old postmenopausal woman presented with abnormal uterine bleeding and a uterine mass. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. The initial postoperative histopathological evaluation suggested undifferentiated endometrial sarcoma; however, subsequent immunohistochemical (IHC) analysis and fluorescence in situ hybridization revealed NUTM1 rearrangement, confirming the diagnosis of NUT carcinoma. The patient experienced tumor recurrence six months postoperatively and succumbed to the disease nine months later. Discussion: The pathological diagnosis was challenging; the presence of abrupt squamous differentiation prompted further IHC analysis, leading to the definitive diagnosis. Primary uterine NUT carcinoma may be misdiagnosed as other undifferentiated uterine tumors due to its rarity and histological overlap. Conclusions: Given the diagnostic challenges, NUT IHC staining and molecular testing for NUTM1 rearrangement should be considered in undifferentiated uterine tumors with ambiguous histopathological features.
KW - nuclear protein in testis (NUT) carcinoma
KW - NUTM1-fusions
KW - undifferentiated carcinoma
KW - uterine corpus cancer
KW - uterine sarcoma
UR - https://www.scopus.com/pages/publications/105028483332
UR - https://www.scopus.com/pages/publications/105028483332#tab=citedBy
U2 - 10.3390/clinpract16010020
DO - 10.3390/clinpract16010020
M3 - Article
AN - SCOPUS:105028483332
SN - 2039-7283
VL - 16
JO - Clinics and Practice
JF - Clinics and Practice
IS - 1
M1 - 20
ER -